Benzgalantamine Gluconate Patent Expiration
Benzgalantamine Gluconate was first introduced by Alpha Cognition Inc
Benzgalantamine Gluconate Patents
Given below is the list of patents protecting Benzgalantamine Gluconate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zunveyl | US11795176 | Solid forms of Alpha-1062 gluconate | Jan 13, 2042 | Alpha Cognition |
| Zunveyl | US9763953 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment | May 16, 2027 | Alpha Cognition |
Benzgalantamine Gluconate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List